These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34246445)

  • 1. Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?".
    Caminati M; Crisafulli E; Lunardi C; Micheletto C; Festi G; Maule M; Giollo A; Orsolini G; Senna G
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2943-2944. PubMed ID: 34246445
    [No Abstract]   [Full Text] [Related]  

  • 2. Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?
    Akdime F; Puéchal X; Roche N
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2942-2943. PubMed ID: 34246444
    [No Abstract]   [Full Text] [Related]  

  • 3. Mepolizumab to treat eosinophilic granulomatosis with polyangiitis.
    Callejas Rubio JL; Moreno Higueras M; Ortego Centeno N
    Med Clin (Barc); 2024 Feb; 162(3):140. PubMed ID: 37567822
    [No Abstract]   [Full Text] [Related]  

  • 4. Justification of the Subcutaneous Mepolizumab Dose of 300 mg in Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome.
    Pouliquen IJ; Austin D; Steinfeld J; Yancey SW
    Clin Ther; 2021 Jul; 43(7):1278-1280. PubMed ID: 34187697
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis.
    Anai M; Yoshida C; Ozono K; Furukawa H; Ishimaru Y; Sakata S; Saruwatari K; Muramoto K; Tomita Y; Saeki S; Ichiyasu H; Sakagami T
    Allergol Int; 2022 Apr; 71(2):259-261. PubMed ID: 35074267
    [No Abstract]   [Full Text] [Related]  

  • 6. Two cases of refractory eosinophilic granulomatosis with polyangiitis wherein mepolizumab was effective against pulmonary and ear lesions.
    Ushio Y; Wakiya R; Kato M; Kameda T; Nakashima S; Shimada H; Mansour MMF; Sugihara K; Miyashita T; Kadowaki N; Dobashi H
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):327-332. PubMed ID: 33533698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. Reply.
    Wechsler ME; Fan Y; Merkel PA
    N Engl J Med; 2024 May; 390(20):1940. PubMed ID: 38810204
    [No Abstract]   [Full Text] [Related]  

  • 8. Eosinophilic granulomatosis with polyangiitis-related myocarditis during mepolizumab therapy reveals a Th1/Th17-mediated vasculitic response.
    Bello F; Emmi G; Tamburini C; Maggi L; Annunziato F; Cosmi L; Prisco D
    Clin Exp Rheumatol; 2022 May; 40(4):863-864. PubMed ID: 35485409
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction in ANCA levels associated with mepolizumab add-on treatment in eosinophilic granulomatosis with polyangiitis: Case series and literature review.
    Kamide Y; Watai K; Nakamura Y; Iwata M; Fukutomi Y; Taniguchi M; Sekiya K
    Allergol Int; 2024 Jan; 73(1):180-183. PubMed ID: 37852914
    [No Abstract]   [Full Text] [Related]  

  • 10. Eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): where are we now?
    Groh M; Pagnoux C; Guillevin L
    Eur Respir J; 2015 Nov; 46(5):1255-8. PubMed ID: 26521277
    [No Abstract]   [Full Text] [Related]  

  • 11. Benralizumab as a Potential Adjunctive Therapy in Eosinophilic Granulomatosis With Polyangiitis.
    Lee Y; Hojjati M
    J Clin Rheumatol; 2021 Dec; 27(8S):S401-S402. PubMed ID: 32453217
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyangiitis overlap syndrome of granulomatosis with polyangiitis (Wegener's granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Uematsu H; Takata S; Sueishi K; Inoue H
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24577169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother.
    Ueki Y; Oshikata C; Asai Y; Kaneko T; Tsurikisawa N
    Intern Med; 2020 Apr; 59(7):991-995. PubMed ID: 31813915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two pediatric cases of ANCA-negative eosinophilic granulomatosis with polyangiitis successfully treated with dupilumab.
    Galant-Swafford J; Geng B; Leibel S; Akuthota P; Tucker S; Cernelc-Kohan M; Sheets R; Nation J; Jefferson AA
    J Allergy Clin Immunol Pract; 2020; 8(10):3643-3646.e1. PubMed ID: 32668296
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current approaches to diagnosing and treating eosinophilic granulomatosis with polyangiitis: The 2015 international guidelines].
    Beketova TV; Volkov MY; Nasonov EL
    Ter Arkh; 2016; 88(5):86-92. PubMed ID: 27239934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mepolizumab is highly effective in a rare case of Wells syndrome: Eosinophilic granulomatosis with polyangiitis overlap.
    Trica OC; Mocan LP; Boit-Trapcea R
    Dermatol Ther; 2022 Nov; 35(11):e15799. PubMed ID: 36045257
    [No Abstract]   [Full Text] [Related]  

  • 17. New-onset eosinophilic granulomatosis with polyangiitis in 2 patients during treatment with IL-5 pathway inhibitors.
    Holubar J; Arnaud E; Broner J; Pers YM; Proust A; Goulabchand R
    Immunol Res; 2022 Dec; 70(6):721-724. PubMed ID: 36125736
    [No Abstract]   [Full Text] [Related]  

  • 18. Mepolizumab and Eosinophilic Pleural Effusion in Patient With Eosinophilic Granulomatosis With Polyangiitis.
    Lorenzo Martínez MDC; Clavería García O; Herrero Mendoza MD; Jareño Esteban JJ
    Arch Bronconeumol; 2023 Jul; 59(7):439-440. PubMed ID: 37059683
    [No Abstract]   [Full Text] [Related]  

  • 19. Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis.
    Moiseev S; Zagvozdkina E; Kazarina V; Bulanov N; Novikov P
    J Allergy Clin Immunol; 2019 Aug; 144(2):621. PubMed ID: 31056188
    [No Abstract]   [Full Text] [Related]  

  • 20. Benralizumab in eosinophilic granulomatosis with polyangiitis.
    Laorden D; Romero D; Domínguez-Ortega J
    Med Clin (Barc); 2022 May; 158(9):441-442. PubMed ID: 34728088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.